The report identifies gaps in the region to turn more science into companies and therapies, highlighting the need for stronger industry relationships and visibility. The Midwest has exceptional science, but collaboration across institutions, investors, and industry is key to unlocking its potential.
Jennifer Frederick, an oncology clinical trial organizer at Wash U Medicine, received the 2026 Alliance Clinical Research Professionals Research Integrity Service Award for her dedication to helping cancer patients access clinical trials. Her work ensures that trials run smoothly and safely, with a focus on patient advocacy and compass...
Alliance Clinical Trials is advancing early detection, improving treatments, and enhancing survivorship for lung cancer patients. The organization is conducting seven active clinical trials focused on prevention, early detection, treatment, and survivorship.
Traditional Chinese medicine trials must meet international standards to generate credible evidence, including clinical questions, experienced trialists, and adequate sample sizes. The trials should be conducted in multiple hospital locations, including Western centers, to build confidence among Western doctors and patients.
SourceSciOpen·JournalEvidence-Based Chinese Medicine and Technology Assessment·DateNov 6, 2026
A new $6.9 million grant from CIRM will support preclinical development of an investigational cell therapy for heart created by USC Stem Cell scientists. The treatment aims to heal cardiac muscle after a severe heart attack, with clinical trials targeting late 2027.
A gene therapy treatment has shown sustained efficacy in patients with Crigler-Najjar syndrome, a rare liver disorder, with two patients able to discontinue phototherapy and one successfully completing a pregnancy. The treatment also normalized liver enzyme levels, paving the way for future therapeutic solutions for rare diseases.
A clinical trial funded by the NIH found that integrated HIV and substance use disorder services delivered through mobile medical units reduced all-cause deaths by 71% compared to community-based services. The trial showed no difference in PrEP and MOUD use, highlighting the need for long-acting PrEP formulations in this population.
Researchers built a machine learning model using 14-year data from 939 SSHL patients to predict healthy ear incidence. The model identified age, hearing loss severity, gender, and cardiovascular and inflammatory indices as key predictors.
Exerkines, exercise-responsive signals, coordinate interorgan crosstalk to regulate glucose and lipid metabolism, insulin sensitivity, and inflammation. Exerkine-based diagnostics and therapeutics hold promise for precision management of chronic metabolic diseases.
The Alliance for Clinical Trials in Oncology is highlighting eight ongoing clinical trials focused on improving cancer detection, treatment, and survivorship for men's cancers. These trials aim to enhance quality of life and support patients and their loved ones after treatment.
Researchers at Vanderbilt-Ingram Cancer Center are investigating a novel approach to treating ovarian cancer by targeting proteins that help tumors evade the immune system. The grant supports development of an imaging approach to track treatment effectiveness and potentially identify patients most likely to benefit from treatment.
This study demonstrates that interleukin-33 alleviates the immunosuppressive tumor microenvironment in hepatocellular carcinoma, activating the STING/IRF axis and increasing functional CD8⁺ T cells. Combining IL-33 with anti-PD-L1 therapy synergistically reduces tumor burden and boosts anti-tumor immunity in vivo.
Researchers found that pegylated interferon-α therapy significantly increases hepatitis B surface antigen clearance in different chronic hepatitis B infection groups, including nucleos(t)ide analogs-experienced patients and children. The therapy achieves high clearance rates in these groups, particularly in those with high baseline lev...
A retrospective study of 30 patients undergoing awake craniotomy found that 30% experienced new or worsened neurological dysfunction within 48–72 hours after surgery. Early functional and cognitive score reductions were common, while new-onset aphasia occurred in 10% of patients. The findings highlight the importance of interpreting ea...
A groundbreaking immunotherapy treatment for rectal cancer has received FDA approval, offering patients with locally advanced rectal cancer the possibility of eliminating their cancer without chemotherapy, radiation, or surgery. The treatment, developed through pioneering research at Memorial Sloan Kettering Cancer Center, has shown a ...
Researchers have identified new predictors of relapse in children with acute lymphoblastic leukemia treated with immunotherapy drug blinatumomab, allowing for more precise treatment tailoring. The study also found genetic subtypes associated with poorer response to treatment and higher risk of relapse.
A new trial shows that a shorter three-week radiation course is as safe and effective as the standard five-week treatment for women undergoing breast reconstruction. The RT CHARM trial found no increase in complications or effects on reconstruction efforts.
Researchers will enroll 1,500 children, ages 0-24 months, and study biological and environmental factors linked to recovery, severe illness, and long-term lung health. The goal is to identify patterns that explain why children follow different paths after an early viral infection.
A new treatment using drug-coated balloons performed just as well as conventional stents in preventing heart attacks and cardiovascular deaths. However, patients treated with drug-coated balloons were more likely to need a repeat procedure in larger arteries.
UT MD Anderson Cancer Center has made significant advancements in cancer care, including the development of a covalent Werner helicase inhibitor, which showed promising antitumor efficacy in a Phase 1 trial. Additionally, a multicenter clinical trial found that tile-based radiation therapy improved tumor control and lowered the risk of...
UChicago Medicine launches a groundbreaking clinical trial testing a new personalized cell therapy for advanced solid tumors, including ovarian cancer and melanoma. The treatment uses specially engineered T-cell receptors to detect hidden cancer proteins, expanding the number of cancers that can be targeted.
Researchers propose recognizing recompensation as a distinct treatment-related disease state, distinguishing stable and unstable recovery, to better capture recovery and continuing risks after cirrhosis treatment. This framework could support more consistent research, clinical assessment, and long-term surveillance for patients recover...
A phase IIIb trial found that PL-5 spray improved healing in infected burn wounds, with higher complete healing and bacterial control compared to placebo. The study enrolled 348 adults and tested the spray's efficacy in reducing wound closure and bacterial clearance.
Juvmo, a Parkinson's disease drug, has been approved by the FDA and offers a new treatment option for patients, potentially reducing side effects. The drug's unique mechanism of action provides relief from motor symptoms, and its approval marks a significant milestone in the research of UVA Health scientists.
CU Anschutz will evaluate emerging technologies and therapeutics for severe hemorrhage, including novel blood products and diagnostic technologies. The award aims to improve care for patients experiencing severe bleeding, including trauma patients and those with postpartum hemorrhage.
A new Cochrane review found insufficient evidence to support the use of medical cannabis for insomnia, with most studies showing little to no improvement in sleep quality and daytime functioning. However, some studies suggested a potential for adverse effects, such as dry mouth and dizziness.
SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateOct 12, 2026
A clinical trial will test a caregiver wellness program for families after traumatic brain injury, aiming to reduce psychological distress and improve coping. The trial will enroll up to 354 patient-caregiver pairs and evaluate the intervention's feasibility, acceptability, and cost.
Researchers found that well-designed digital alerts can assist clinicians in high-pressure situations, prompting them to make recommended treatment decisions and recognize when patients are deteriorating. The studies demonstrated the effectiveness of electronic health record alerts in the emergency department and cardiac intensive care...
The AFT-70 NAVIGATE trial tests a novel molecular residual disease-guided treatment strategy for ER-positive/HER2-negative breast cancer patients. The trial pairs giredestrant with longitudinal Signatera Genome MRD monitoring to identify patients who may benefit from treatment escalation with a CDK4/6 inhibitor.
Mount Sinai has launched an international clinical trial to determine the optimal treatment for spontaneous coronary artery dissection (SCAD), a sudden tear in the wall of a heart artery that can reduce blood flow and cause an uncommon type of heart attack. The trial, known as SCAD-ALIGN, will compare a moderate antiplatelet strategy o...
A new tool, INSPECT-SR, has been developed to assess the trustworthiness of randomized controlled trials (RCTs) and identify problematic studies. This tool, which has been endorsed by the Cochrane community, provides a rigorous and transparent method for reviewers to evaluate the integrity of trial data.
A new drug, Kamuvudine K-9, has been shown to preserve nerve fibers and halt neurological damage in a mouse model of multiple sclerosis. The drug, derived from HIV drugs, has been found to be more effective than existing treatments in restoring function and reducing inflammation.
Researchers tested a potential drug combination for metastatic uveal melanoma, uncovering clues about treatment resistance. The study found that levels of an enzyme called ALDH1A3 increased after treatment in patients whose disease progressed, while those whose disease remained stable had lower levels.
Researchers propose using carefully designed combinations of approved drugs to create a more convincing placebo, limiting participant disclosure, and rigorous testing to ensure effective masking. This approach, called UMBRAA, aims to overcome the challenge of distinguishing between psychedelic effects and the power of expectation.
A new brain-computer interface (BCI) allows people with vocal tract and bodily paralysis to convey both speech and upper-body gestures simultaneously. The BCI successfully translated the thoughts of patients into commands that dictated the expressions of a full-body virtual avatar.
Insilico Medicine has dosed the first patient in the GENESIS-IPF-3 Phase III clinical trial of Rentosertib, a generative AI-driven innovative drug for idiopathic pulmonary fibrosis. The 52-week trial aims to evaluate Rentosertib's efficacy and safety in a larger cohort of patients with IPF.
Researchers found that fish serotonin transporters, similar to human counterparts, can be highly sensitive to antidepressants found in water, highlighting potential risks to aquatic life. The study suggests prioritizing specific pharmaceuticals in environmental monitoring programs and deriving species-specific risk thresholds.
A clinical trial shows that laughter therapy can reduce breathing difficulties and is as effective as traditional breathing exercises in COPD patients. Patients who underwent laughter therapy had less difficulty breathing and better overall health compared to those who received traditional breathing exercises or no treatment.
A new study at the University of Oklahoma is testing an interactive app called Connect2Care to increase prostate cancer screening among Black men in Oklahoma. The app provides culturally tailored education, guides users through at-home PSA testing, and connects them with medical professionals.
A phase 2 clinical trial found that a less-intensive combination of azacitidine and venetoclax was more effective in treating acute myeloid leukemia, with patients tolerating treatment better and spending less time in the hospital. The combination also led to more patients reaching stem cell transplantation.
A clinical trial funded by NIH found that PAXLOVID does not improve Long COVID symptoms, but its extended duration did not cause serious side effects. The study recruited 959 patients and monitored symptoms over six months.
Prostate cancer affects 1 in 8 men, with 60% diagnosed in men 65 and older. Clinical trials like Alliance's help improve early detection and treatment, reducing mortality rates by half since 1993. These trials also explore new treatments and survivorship strategies.
A phase 2 clinical trial found that a monoclonal antibody targeting interleukin-6 achieved sustained reductions in inflammation biomarkers for six months in patients with chronic kidney disease. The therapy, known as pacibekitug, was well-tolerated and showed favorable effects on additional biomarkers associated with cardiovascular risk.
Researchers at Charité report significant success in treating severe rheumatoid arthritis with CD19 CAR T cells, reducing disease activity and promoting sustained remission in patients. The treatment targets disease-driving B cells, allowing the immune system to reset and eliminate harmful antibodies.
The Alliance for Clinical Trials in Oncology has released a film highlighting the importance of clinical trials in cancer research, featuring the story of a lung cancer patient who participated in a trial. The film emphasizes the human element of research and explores how individual participation contributes to progress in cancer care.
This review explores the impact of tryptophan metabolism on female reproductive health, including ovarian function, fertility, and maternal-fetal health. It highlights the therapeutic potential of tryptophan metabolism in treating ovarian diseases and proposes dietary supplementation, modulation of the gut microbiota, and melatonin ant...
A new research tool, PGS-TRI, analyzes family data to understand how genetics and environment contribute to autism risk. The tool provides a more precise look at how 'nature' and 'nurture' interact within families, allowing researchers to better understand the complex factors that shape a child's health.
A new study by the University of Illinois Chicago found that time-restricted eating may be a safe and effective tool to control blood sugar levels in adults with Type 1 diabetes. The study, led by Krista Varady, showed a significant reduction in blood sugar levels after six months, with no increased risk of extreme highs or lows.
Professors Etienne Cavalier and Roland Chapurlat assume leadership as Co-Editors-in-Chief, bringing complementary expertise in laboratory science, translational research, and clinical investigation. They aim to build on the journal's strong foundations and further enhance its role in musculoskeletal research.
A new study reveals that fluctuations in estrogen influence brain connections in rats, using a specialized imaging technique called magnetic resonance elastography (MRE). Researchers hope to translate the findings to humans, exploring how hormonal changes affect brain health in women, particularly during menopause.
The Alliance for Clinical Trials in Oncology emphasizes the significance of clinical trials in advancing breast cancer treatments and early detection. The organization's work has led to a 44% decline in breast cancer mortality rates among women since 1989.
A new study suggests that a video game designed to raise teens' awareness of mental health issues can reduce symptoms of depression on par with in-school programs. The game, PlaySmart, was played by 269 students for up to six weeks, with significant reductions in symptoms reported after only six weeks.
A new book by University of Virginia Health System expert Daniel J. Cox outlines a practical alternative to medication for managing pre-diabetes and type 2 diabetes. The GEM program emphasizes smart eating, physical activity, and listening to the body to regulate blood sugar levels.
The RadiCaL study, the first randomized trial of a radiopharmaceutical in kidney cancer, found that adding radium-223 to the standard of care does not improve skeletal event-free survival. Patients who received the combination treatment lived a median of 28.3 months, compared with 19.7 months for those who received cabozantinib alone.
A new clinical trial at HonorHealth Research Institute uses a vaccine-based on immune system dendritic cells to fight advanced melanoma. The vaccine has shown promising results in treating refractory and unresectable cases of the disease, with a 10-fold increase in immune response.
The partnership aims to increase enrollment in clinical trials, making research opportunities more accessible to patients. UCCCC and Lilly will work together to open studies faster and connect more patients with research opportunities.
A new Cochrane review analyzed 11 studies involving 2,524 women undergoing embryo transfer, finding no reliable evidence that preparatory techniques improve IVF success rates. The techniques examined included straightening the utero-cervical angle and removing cervical mucus before transfer.
SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateAug 5, 2026
ISM8969/HT-001 is an orally available, brain-penetrant NLRP3 inhibitor with promising in vitro and in vivo profiles. The clinical trial aims to evaluate its safety, tolerability, and efficacy in patients with Parkinson's disease.
A pilot clinical trial of psilocybin-assisted therapy in veterans with severe PTSD found that 75% of participants were in remission one month after treatment, with no serious adverse events reported. The results suggest the protocol may be a game-changer for those struggling with treatment-resistant PTSD.
ISM6331, a novel pan-TEAD inhibitor, has received Fast Track Designation from the FDA for treating adult patients with unresectable malignant pleural mesothelioma. The treatment boasts synergistic anti-tumor effects and potential to overcome drug resistance as combination therapy.